EMEA-002395-PIP01-18 - paediatric investigation plan
atorvastatin (calcium trihydrate)
Indapamide
perindopril arginine
PIPHuman
Les Laboratoires Servier
E-mail: mail.pip.enquiries@servier.com
Tel. +33 1557 26000
P/0333/2018: EMA decision of 8 October 2018 on the granting of a product-specific waiver for atorvastatin (calcium trihydrate) / perindopril (arginine) / indapamide (EMEA-002395-PIP01-18)